These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6220671)

  • 1. Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715).
    Shungu DL; Weinberg E; Gadebusch HH
    Antimicrob Agents Chemother; 1983 Feb; 23(2):256-60. PubMed ID: 6220671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1983 Jun; 1(2):165-72. PubMed ID: 6232084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disk diffusion susceptibility tests with norfloxacin: confirmation of proposed interpretive criteria.
    Wood SJ; Shadomy S
    Eur J Clin Microbiol; 1983 Jun; 2(3):242-4. PubMed ID: 6224680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agents.
    Gadebusch HH; Shungu DL; Weinberg E; Chung SK
    Infection; 1982 Jan; 10(1):41-4. PubMed ID: 6461606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activity of norfloxacin (MK-0366).
    King A; Warren C; Shannon K; Phillips I
    Antimicrob Agents Chemother; 1982 Apr; 21(4):604-7. PubMed ID: 6211139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteria.
    Fuchs PC; Jones RN; Barry AL; Ayers LW; Gavan TL; Gerlach EH; Thornsberry C
    Diagn Microbiol Infect Dis; 1987 May; 7(1):29-35. PubMed ID: 3121241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.
    Ayers LW; Jones RN; Barry AL; Thornsberry C; Fuchs PC; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1982 Nov; 22(5):859-77. PubMed ID: 6983862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.
    Shungu DL; Weinberg E; Gadebusch HH
    Antimicrob Agents Chemother; 1983 Jan; 23(1):86-90. PubMed ID: 6219622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative activities of norfloxacin and fifteen other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa strains.
    Forward KR; Harding GK; Gray GJ; Urias BA; Ronald AR
    Antimicrob Agents Chemother; 1983 Oct; 24(4):602-4. PubMed ID: 6228193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria.
    Fuchs PC; Barry AL; Jones RN; Thornsberry C; Ayers LW; Gavan TL; Gerlach EH
    Diagn Microbiol Infect Dis; 1987 Mar; 6(3):185-92. PubMed ID: 3471371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.
    Wise R; Andrews JM; Edwards LJ
    Antimicrob Agents Chemother; 1983 Apr; 23(4):559-64. PubMed ID: 6222695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limits.
    Fuchs PC; Barry AL; Jones RN; Thornsberry C
    Diagn Microbiol Infect Dis; 1985 May; 3(3):213-21. PubMed ID: 3858044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Types of interpretive errors in susceptibility testing. Zone breakpoints for norfloxacin disk diffusion testing.
    Björklind A; Ringertz S; Kronvall G
    APMIS; 1989 Oct; 97(10):941-8. PubMed ID: 2803757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.
    Fuchs PC; Barry AL; Thornsberry C; Jones RN; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1980 Jul; 18(1):88-93. PubMed ID: 6251750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tentative disk diffusion susceptibility interpretive criteria for pefloxacin.
    Fuchs PC; Barry AL; Jones RN; Thornsberry C
    J Clin Microbiol; 1986 Sep; 24(3):448-50. PubMed ID: 3463566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative activity of norfloxacin with other antimicrobial agents against Gram-positive and Gram-negative bacteria.
    Corrado ML; Cherubin CE; Shulman M
    J Antimicrob Chemother; 1983 Apr; 11(4):369-76. PubMed ID: 6222023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temafloxacin disk potency and tentative interpretive criteria for susceptibility tests.
    Barry AL; Jones RN
    J Clin Microbiol; 1989 Dec; 27(12):2861-3. PubMed ID: 2592548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.
    Barry AL; Jones RN; Thornsberry C; Ayers LW; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1984 May; 25(5):633-7. PubMed ID: 6233935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
    Muytjens HL; van der Ros-van de Repe J; van Veldhuizen G
    Antimicrob Agents Chemother; 1983 Aug; 24(2):302-4. PubMed ID: 6227281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A
    Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.